Part II In Vivo Magnetic Resonance Spectroscopy in Breast Cancer
Uma Sharma
Abstract
Uma Sharma
Abstract
Abbreviations: MR, magnetic resonance; MRI, magnetic resonance imaging; MRS, magnetic resonance spectroscopy; 1 H MRS, proton magnetic resonance spectroscopy; 31 P MRS, phosphorus magnetic resonance spectroscopy; CE-MRI, contrast-enhanced magnetic resonance imaging; VOI, volume of interest; CSI, chemical shift imaging; MRSI, magnetic resonance spectroscopic imaging; STEAM, stimulated echo acquisition mode; PRESS, point resolved spectroscopy; CHESS, chemical shift selective; W–F, water-to-fat ratio; PME, phosphomonoester; PDE, phosphodiester; PCr, phosphocreatine; SV, single-voxel.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Abbreviations: MR, magnetic resonance; MRI, magnetic resonance imaging; MRS, magnetic resonance spectroscopy; 1 H MRS, proton magnetic resonance spectroscopy; 31 P MRS, phosphorus magnetic resonance spectroscopy; CE-MRI, contrast-enhanced magnetic resonance imaging; VOI, volume of interest; CSI, chemical shift imaging; MRSI, magnetic resonance spectroscopic imaging; STEAM, stimulated echo acquisition mode; PRESS, point resolved spectroscopy; CHESS, chemical shift selective; W–F, water-to-fat ratio; PME, phosphomonoester; PDE, phosphodiester; PCr, phosphocreatine; SV, single-voxel.
Key concepts: Nuclear magnetic resonance, Nuclear magnetic resonance spectroscopy, Magnetic resonance imaging, Spectroscopy, Chemistry, Magnetic resonance spectroscopic imaging, Phosphocreatine, Proton magnetic resonance